Elevance Health Inc. (NYSE:ELV)

Over the observed period, the common stock valuation ratios exhibited distinct trends. Generally, a decreasing pattern is apparent across all ratios analyzed, particularly pronounced in the latter half of the period. This suggests a potential shift in investor sentiment or a reassessment of the company’s value proposition.

Price to Earnings (P/E)

The Price to Earnings ratio began at 20.46 and generally decreased, although with some fluctuation, to 13.21. A slight increase is observed in the most recent quarter, reaching 15.88 and then 12.71. This indicates that the market is paying less for each dollar of the company’s earnings over time, potentially reflecting concerns about future earnings growth or increased risk. The decline is not monotonic, with increases observed between September 2022 and December 2022, and again between March 2024 and March 2025, before resuming the downward trend.

Price to Operating Profit (P/OP)

The Price to Operating Profit ratio followed a similar trajectory to the P/E ratio, starting at 17.53 and decreasing to 11.39. The decline is relatively consistent, with a more pronounced decrease observed from December 2022 onwards. This suggests a diminishing valuation relative to the company’s operational profitability. The ratio experienced a slight increase between September 2023 and December 2023, but then resumed its downward trend.

Price to Sales (P/S)

The Price to Sales ratio demonstrated a consistent downward trend throughout the period, moving from 0.89 to 0.38. This is the most significant and consistent decline among the ratios examined, indicating a substantial decrease in the valuation assigned to each dollar of revenue. The decrease accelerated in the latter half of the period, suggesting a growing disconnect between the stock price and the company’s sales performance.

Price to Book Value (P/BV)

The Price to Book Value ratio also exhibited a declining trend, starting at 3.55 and ending at 1.70. While fluctuations are present, the overall direction is downward, suggesting that the market is valuing the company’s net assets at a decreasing multiple. The most substantial decrease occurred between March 2024 and June 2025, indicating a significant shift in the perceived value of the company’s assets. A slight increase is observed between December 2024 and March 2025, but this is followed by a further decline.

In summary, the observed trends across these valuation ratios suggest a decreasing market valuation of the company. The consistent declines in P/S and P/BV, coupled with the downward trend in P/E and P/OP, warrant further investigation into the underlying factors driving these changes.

The price to earnings (P/E) ratio for the observed period demonstrates a generally decreasing trend, punctuated by periods of relative stability and modest increases. Initial values indicate a P/E ratio fluctuating around 18 to 20 in the first half of 2022, followed by a decline towards the end of 2022 and continuing into 2023. A more pronounced decrease is evident in the latter half of 2023 and into 2024, reaching a low point before a slight recovery in late 2024 and early 2025.

Initial Period (Mar 31, 2022 – Dec 31, 2022)

The P/E ratio began at 20.46 and experienced a decrease to 19.20 over this period. While fluctuations occurred, the ratio remained within a relatively narrow range, suggesting a consistent, though not dramatic, valuation relative to earnings.

2023 Trend

Throughout 2023, the P/E ratio generally declined from 17.46 to 13.21. This suggests a decreasing investor willingness to pay for each dollar of earnings, potentially reflecting increased risk perception or changing market conditions. The most significant drop occurred between September 30, 2023, and December 31, 2023.

2024-2025 Fluctuations

The P/E ratio reached its lowest point at 12.71 in June 2025. Prior to this, a slight increase was observed from 14.85 in December 2023 to 15.88 in March 2024, followed by a more substantial decline to 12.71. A modest recovery is then seen, with the ratio increasing to 14.05 and 13.21 by the end of the observed period. This suggests some stabilization, but overall valuations remain lower than those observed in the earlier part of the period.

Relationship to Share Price and EPS

The observed P/E ratio movements correlate with changes in both share price and earnings per share. The decline in the P/E ratio is attributable to a combination of decreasing share price and, to a lesser extent, fluctuating earnings per share. While EPS remained relatively stable, the more significant declines in share price contributed to the overall downward trend in the P/E ratio.

In summary, the P/E ratio experienced a notable decline over the analyzed timeframe, indicating a shift in market valuation. The latter portion of the period shows some signs of stabilization, but the ratio remains considerably lower than its initial values. These changes warrant further investigation into the underlying factors influencing both share price and earnings.

The Price to Operating Profit (P/OP) ratio for the observed period demonstrates a generally decreasing trend, punctuated by periods of relative stability and minor increases. Initial values indicate a ratio around 17.5, followed by a decline and subsequent fluctuations before settling at lower levels towards the end of the period.

Overall Trend

The P/OP ratio began at 17.53 in March 2022 and generally decreased to 11.39 by December 2025. This suggests a relative decrease in the valuation assigned to each dollar of operating profit generated by the company over the observed timeframe. The most significant decline occurred between March 2023 and June 2025.

Initial Phase (March 2022 - December 2022)

From March 2022 to December 2022, the P/OP ratio exhibited a moderate decrease, moving from 17.53 to 15.05. This initial decline could be attributed to various factors, including market adjustments or evolving investor expectations regarding future profitability.

Fluctuating Period (March 2023 - September 2023)

The period from March 2023 to September 2023 showed some fluctuation, with the ratio moving from 13.61 to 14.38. This suggests a period of uncertainty or mixed signals influencing investor sentiment.

Significant Decline (December 2023 - June 2025)

A more pronounced downward trend was observed from December 2023 through June 2025, with the P/OP ratio decreasing from 15.57 to 9.63. This substantial decline indicates a significant shift in market valuation relative to operating profit. The ratio experienced a slight recovery to 11.39 by December 2025, but remained considerably lower than the initial values.

Correlation with Share Price and Operating Profit

The decrease in the P/OP ratio appears to be influenced by both a decline in the share price and a relatively stable operating profit per share. While operating profit per share generally increased from $30.22 to $29.77, the share price experienced a more substantial decrease from $529.84 to $338.98, contributing to the overall reduction in the P/OP ratio.

In conclusion, the observed trend in the P/OP ratio suggests a decreasing market valuation relative to operating profit, potentially reflecting investor concerns or a reassessment of the company’s future growth prospects. The period from December 2023 to June 2025 witnessed the most significant decline, warranting further investigation into the underlying drivers of this change.

The Price to Sales (P/S) ratio for the analyzed period demonstrates a generally decreasing trend, punctuated by periods of relative stability. Initial values indicate a ratio of 0.89, followed by a decline to 0.74. Subsequently, the ratio experienced a slight increase before embarking on a more pronounced downward trajectory beginning in the first quarter of 2023.

Overall Trend

From March 31, 2022, through December 31, 2025, the P/S ratio exhibits an overall decreasing trend. The ratio decreased from 0.89 to 0.38, representing a substantial decline over the observed period.

Initial Phase (Mar 31, 2022 – Dec 31, 2022)

The period between March 31, 2022, and December 31, 2022, shows a moderate decrease in the P/S ratio, moving from 0.89 to 0.74. This initial decline suggests a potential shift in investor sentiment or a relative increase in sales compared to the share price.

Stabilization and Subsequent Decline (Jan 1, 2023 – Dec 31, 2023)

The first half of 2023 saw relative stability, with the P/S ratio fluctuating between 0.68 and 0.70. However, the second half of 2023 and the first half of 2024 witnessed a continued decline, reaching a low of 0.60 by June 30, 2024. This suggests increasing pressure on the share price relative to sales.

Accelerated Decrease (Mar 31, 2024 – Dec 31, 2025)

The period from March 31, 2024, to December 31, 2025, demonstrates an accelerated decrease in the P/S ratio. The ratio fell from 0.71 to 0.38, indicating a significant divergence between the share price and sales. This could be attributed to various factors, including market conditions, company-specific challenges, or changes in investor expectations.

Sales per Share Trend

Concurrently, Sales per Share consistently increased throughout the period, rising from 592.04 to 895.24. This upward trend in sales per share contrasts with the declining P/S ratio, reinforcing the observation that the decrease in the P/S ratio is primarily driven by share price performance rather than a decline in sales.

In summary, the P/S ratio experienced a consistent downward trend over the analyzed period, despite increasing sales per share. This suggests that the market valuation of the company, relative to its sales, has decreased significantly.

The price to book value (P/BV) ratio for the analyzed period demonstrates a generally decreasing trend, punctuated by periods of relative stability and minor increases. Initial values indicate a P/BV around 3.5, which subsequently declines over the observed timeframe.

Initial Period (Mar 31, 2022 – Dec 31, 2022)

The P/BV ratio begins at 3.55 and experiences a moderate decrease to 3.19 over this period. While fluctuations occur, the ratio remains within a relatively narrow range, suggesting a consistent, albeit slightly declining, valuation relative to book value.

Declining Trend (Mar 31, 2023 – Dec 31, 2024)

A more pronounced downward trend is observed, with the P/BV ratio decreasing from 2.90 to 2.15. This suggests a growing disconnect between market price and book value, potentially indicating investor concerns or a reassessment of the company’s asset valuation. The ratio briefly stabilizes around 3.0 during the first half of 2023, but then resumes its decline.

Significant Decrease & Stabilization (Mar 31, 2025 – Dec 31, 2025)

The most substantial decrease in the P/BV ratio occurs during this period, falling from 2.21 to 1.70. This represents a significant shift in investor perception, potentially driven by company-specific factors or broader market conditions. The ratio shows some stabilization towards the end of the period, but remains at its lowest point within the analyzed timeframe.

Overall, the P/BV ratio exhibits a clear downward trajectory, indicating that the market value of the equity is decreasing relative to the company’s book value. This trend warrants further investigation to determine the underlying causes and potential implications for future performance.